Skip to content Skip to sidebar Skip to footer

Tech Stocks

Test text

Telix Pharmaceuticals (ASX:TLX) Back on Track, First Patient Dosed in Phase 3 PROSTACT Trial

TLX Delivers Clinical Progress It’s good to finally see some positive news from Telix Pharmaceuticals (ASX:TLX) after a relatively quiet period, especially following recent market nerves around the FDA slowdown and a few ASX announcement missteps. Today, the company reported an important milestone in its PROSTACT Global Phase 3 trial, confirming that the first patient…

ByCharlie YouldenDecember 8, 2025

ASX Tech Stocks Down 22%: Buy the Dip or Stay Away?

ASX tech stocks: Opportunity or Warning Sign? The Australian tech sector has taken a big hit. The S&P/ASX 200 Information Technology Index (ASX: XIJ) has fallen 22% since mid-September, when it reached a record high of 3,060 points. In contrast, the broader ASX 200 has only slipped 2% over the same time. This sharp fall…

ByUjjwal MaheshwariDecember 8, 2025

DorsaVi (ASX:DVL) is Combining the Best of 3 Worlds for Tomorrow’s Edge AI Devices

Silicon With a Brain DorsaVi’s (ASX:DVL) Resistive Random Access Memory (ReRAM) development is progressing toward integration at the 22nm (nanometer) technology node. Now, for many investors, this is highly technical language, but the key point is simple and we will break down what all this means for the company and how it ties into its…

ByCharlie YouldenDecember 5, 2025

Nuix (ASX: NXL) Acquires Linkurious for $35M to Boost Graph-Powered AI Capabilities

Nuix bets on graph intelligence to rebuild investor confidence after a tough year. Nuix (ASX: NXL) has agreed to acquire French graph-intelligence company Linkurious SAS in a deal worth up to A$35.4 million. For a company whose shares have fallen more than 70 per cent this year, this acquisition could mark a turning point. Shares rose…

ByUjjwal MaheshwariDecember 5, 2025

Argenica (ASX: AGN) Jumps 22% as ARG-007 Clears Critical FDA Hurdle

Argenica’s ARG-007 Clears the Way Argenica Therapeutics (ASX: AGN) surged 22% today after confirming that its tenecteplase drug interaction study for ARG 007 met a key FDA requirement needed to lift the clinical hold on its US Investigational New Drug application. The study showed that ARG 007 does not interfere with the clot-dissolving activity of…

ByCharlie YouldenDecember 4, 2025

Invion (ASX: IVX) Lights Up as Shares Surge 37% on Global Photosoft Deal

Invion’s Global Photosoft Play Positions It as a Leader in PDT Invion (ASX: IVX) surged 37% today after announcing it has secured perpetual, exclusive global rights to the Photosoft™ therapy platform, significantly expanding its patented pipeline across both human and animal health applications, including oncology, infectious diseases, and cardiovascular disorders. Under the new agreement, Invion…

ByCharlie YouldenDecember 3, 2025

Titomic (ASX: TTT) Surges 12% After Successful Hot-Fire Test of Additively Manufactured Rocket Chamber

Titomic Proves Its Tech Can Take the Heat Titomic (ASX: TTT) has faced a challenging few months, with shares falling nearly 50% from their yearly highs. However, the stock surged 12% today following a major technical milestone: the company successfully completed a hot-fire test on a solid rocket motor thrust chamber that was additively manufactured…

ByCharlie YouldenDecember 2, 2025

Sea Forest (ASX: SEA) Eyes a $10 Billion Market as Its Methane-Cutting Feed Gains Momentum

Why Sea Forest Could Be a $10 Billion Game Changer Sea Forest (ASX: SEA) has gained significant momentum, rising 33% over the past month and surging another 30 percent today following its investor webinar. In this article, we look at the company’s addressable market, the scale of the opportunity, and why this recent IPO has…

ByCharlie YouldenDecember 1, 2025

Here are 5 stocks with significant exposure to crypto! Are you better off investing in them instead of trading currencies yourself?

Stocks with significant exposure to crypto might be worth considering if you want exposure to cryptocurrencies, but without the troubles that come with investing in the raw currency, such as volatility and the question of storage. Stocks Down Under recaps 5 companies with exposure to crypto and then discusses whether the better choice for investors is…

ByNick SundichDecember 1, 2025

Amazon Shares Soar 11% On Its Strongest Quarter as AWS Reignites Growth and Reclaims Its AI Edge

Amazon Shares Soar as Investors See Its Growth Story Isn’t Over Yet, AWS Just Proved It Amazon shares rallied as the Great White Shark of Seattle delivered an exceptional third quarter, with shares jumping 11% after hours to around $249. What stood out most this quarter was how quickly investor sentiment toward AWS turned around.…

ByCharlie YouldenOctober 31, 2025

the Kick-ass Multipurpose WordPress Theme

Tech Stocks

Telix Pharmaceuticals (ASX:TLX) Back on Track, First Patient Dosed in Phase 3 PROSTACT Trial

ASX Tech Stocks Down 22%: Buy the Dip or Stay Away?

DorsaVi (ASX:DVL) is Combining the Best of 3 Worlds for Tomorrow’s Edge AI Devices

Nuix (ASX: NXL) Acquires Linkurious for $35M to Boost Graph-Powered AI Capabilities

Argenica (ASX: AGN) Jumps 22% as ARG-007 Clears Critical FDA Hurdle

Invion (ASX: IVX) Lights Up as Shares Surge 37% on Global Photosoft Deal

Titomic (ASX: TTT) Surges 12% After Successful Hot-Fire Test of Additively Manufactured Rocket Chamber

Sea Forest (ASX: SEA) Eyes a $10 Billion Market as Its Methane-Cutting Feed Gains Momentum

Here are 5 stocks with significant exposure to crypto! Are you better off investing in them instead of trading currencies yourself?

Amazon Shares Soar 11% On Its Strongest Quarter as AWS Reignites Growth and Reclaims Its AI Edge

Investing in the Year of the Rat

2020, the Golden Year

Market trouble spots to avoid in 2020

Tech Stocks

Add Your Heading Text Here